Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Top Cited Papers
- 10 February 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 19 (3), 149-150
- https://doi.org/10.1038/d41573-020-00016-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- First Case of 2019 Novel Coronavirus in the United StatesThe New England Journal of Medicine, 2020
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoVChemBioChem, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus InfectionsChemistry – An Asian Journal, 2019
- Approved Antiviral Drugs over the Past 50 YearsClinical Microbiology Reviews, 2016
- Coronaviruses — drug discovery and therapeutic optionsNature Reviews Drug Discovery, 2016